NCT04645420View on ClinicalTrials.gov

Molecular Effects of Apremilast in the Synovium of Psoriatic Arthritis Patients

NACompletedINTERVENTIONAL
Enrollment

19

Participants

Timeline

Start Date

November 12, 2020

Primary Completion Date

January 10, 2023

Study Completion Date

February 10, 2023

Conditions
Psoriatic Arthritis
Interventions
PROCEDURE

Global gene expression profiles obtained from synovial biopsies.

Global gene expression profiles obtained from synovial biopsies before and after 24 weeks of treatment with the drug in each patient.

Trial Locations (1)

1200

Adrien NZEUSSEU TOUKAP, Brussels

Sponsors

Collaborators (1)

Amgen
All Listed Sponsors
collaborator

Amgen

INDUSTRY

lead

Cliniques universitaires Saint-Luc- Université Catholique de Louvain

OTHER